Back
Arcturus Therapeutics Holdings Stock Price Chart
Buy
61
ARCT
Arcturus Therapeutics Holdings
Last Price:
29.78
Seasonality Move:
25.77%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is relatively stagnant and ARCT is experiencing selling pressure, which indicates risk of future bearish movement.
Arcturus Therapeutics Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.63 | Buy |
| 20-day SMA: | 27.62 | Buy |
| 50-day SMA: | 30.69 | Sell |
| 200-day SMA: | 29.4 | Buy |
| 8-day EMA: | 28.96 | Buy |
| 20-day EMA: | 28.56 | Buy |
| 50-day EMA: | 30.07 | Sell |
| 200-day EMA: | 29.67 | Buy |
Arcturus Therapeutics Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 53.86 | Buy |
| Chaikin Money Flow: | -214169 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.33 - 29.03) | Buy |
| Bollinger Bands (100): | (28.96 - 37.08) | Sell |
Arcturus Therapeutics Holdings Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arcturus Therapeutics Holdings Stock
Is Arcturus Therapeutics Holdings Stock a Buy?
- Arcturus Therapeutics Holdings share price is 29.78 while ARCT 8-day simple moving average is 28.63, which is a Buy signal.
- The stock price of ARCT is 29.78 while Arcturus Therapeutics Holdings 20-day SMA is 27.62, which makes it a Buy.
- Arcturus Therapeutics Holdings 50-day simple moving average is 30.69 while ARCT share price is 29.78, making it a Sell technically.
- ARCT stock price is 29.78 and Arcturus Therapeutics Holdings 200-day simple moving average is 29.40, creating a Buy signal.
ARCT Technical Analysis vs Fundamental Analysis
Buy
61
Arcturus Therapeutics Holdings (ARCT)
is a Buy
Is Arcturus Therapeutics Holdings a Buy or a Sell?
-
Arcturus Therapeutics Holdings stock is rated a Buy
The current Arcturus Therapeutics Holdings [ARCT] share price is $29.78. The Score for ARCT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Arcturus Therapeutics Holdings Stock Info
Market Cap:
802.03M
Price in USD:
29.78
Share Volume:
354.61K
Arcturus Therapeutics Holdings 52-Week Range
52-Week High:
43.81
52-Week Low:
17.52
Buy
61
Arcturus Therapeutics Holdings (ARCT)
is a Buy
Arcturus Therapeutics Holdings Share Price Forecast
-
What is the Arcturus Therapeutics Holdings stock price today?
The Arcturus Therapeutics Holdings stock price is 29.78 USD today. -
Will ARCT stock go up or go down?
Arcturus Therapeutics Holdings> share price is forecast to RISE/FALL based on technical indicators -
Is Arcturus Therapeutics Holdings overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcturus Therapeutics Holdings is not overvalued.
Is Arcturus Therapeutics Holdings Stock a Buy?
- Arcturus Therapeutics Holdings share price is 29.78 while ARCT 8-day exponential moving average is 28.96, which is a Buy signal.
- The stock price of ARCT is 29.78 while Arcturus Therapeutics Holdings 20-day EMA is 28.56, which makes it a Buy.
- Arcturus Therapeutics Holdings 50-day exponential moving average is 30.07 while ARCT share price is 29.78, making it a Sell technically.
- ARCT stock price is 29.78 and Arcturus Therapeutics Holdings 200-day simple moving average is 29.67, creating a Buy signal.
Fundamental Analysis of Arcturus Therapeutics Holdings
Is Arcturus Therapeutics Holdings a good investment?
- Analysts estimate an earnings decrease this quarter of $0.93 per share, an increase next quarter of $0.25 per share, a decrease this year of $0.79 per share, and an increase next year of $1.48 per share.
Technical Analysis of Arcturus Therapeutics Holdings
Should I short Arcturus Therapeutics Holdings stock?
- ARCT Moving Average Covergence Divergence (MACD) indicator is -0.21, suggesting Arcturus Therapeutics Holdings is a Sell
- Arcturus Therapeutics Holdings Relative Strength Index (RSI) is 53.86, which suggest Arcturus Therapeutics Holdings is overbought
- The Bollinger Bands (25) for Arcturus Therapeutics Holdings is (26.33 - 29.03), which suggest Arcturus Therapeutics Holdings is a Sell
- The Bollinger Bands (100) for Arcturus Therapeutics Holdings is (28.96 - 37.08), which suggest Arcturus Therapeutics Holdings is a Sell
* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.